Palisade Bio Inc. (NASDAQ: PALI)
$2.4900
+0.0500 ( +2.05% ) 34.5K
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Market Data
Open
$2.4900
Previous close
$2.4400
Volume
34.5K
Market cap
$3.75M
Day range
$2.4250 - $2.5450
52 week range
$2.1800 - $22.3500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 17 | May 10, 2024 |
| 4 | Insider transactions | 1 | May 08, 2024 |
| 4 | Insider transactions | 1 | May 08, 2024 |
| 8-k | 8K-related | 21 | May 03, 2024 |
| 8-k | 8K-related | 43 | Apr 10, 2024 |
| 8-k | 8K-related | 16 | Apr 05, 2024 |
| 8-k | 8K-related | 15 | Mar 27, 2024 |
| 10-k | Annual reports | 74 | Mar 26, 2024 |
| 4 | Insider transactions | 1 | Mar 12, 2024 |
| 8-k | 8K-related | 15 | Mar 06, 2024 |